1001
|
|
|
Synuclein alpha |
NACP, PARK1, PARK4, PD1 |
Alzheimer disease, Amphetamine or sympathomimetic abuse, Ataxia, Parkinson disease, Congestive heart failure, Deficiency anemia, Degenerative disorder, Dementia, Vascular dementia, Diabetic ketoacidosis, Duchenne muscular dystrophy, Gaucher disease, Heart failure, Hemiparkinsonism, Hepatolenticular degeneration, Hereditary parkinson disease, Idiopathic pulmonary fibrosis, Insomnia, Lewy body disease, Neurodegenerative disorder, Neurotic disorder, Secondary parkinson disease, Parkinsonian-pyramidal syndrome, Substance-induced psychosis, Schizophrenia, Diabetes mellitus type 2View all (11 more) |
1002
|
|
|
Synuclein alpha interacting protein |
SYPH1, Sph1 |
|
1003
|
|
|
Synuclein beta |
- |
|
1004
|
|
|
Synuclein gamma |
BCSG1, SR |
|
1005
|
|
|
Staphylococcal nuclease and tudor domain containing 1 |
TDRD11, TSN, Tudor-SN, p100 |
Attention deficit hyperactivity disorder, Autism, Kidney disease, Hemorrhoid, Hypospadias, Insomnia, Kidney failure, Lung neoplasms, Oligodendroglioma, Peptic ulcer disease, Schizophrenia, Substance abuse, Diabetes mellitus type 2 |
1006
|
|
|
SNF8 subunit of ESCRT-II |
DEE115, Dot3, EAP30, NEDOA, VPS22 |
|
1007
|
|
|
Smad nuclear interacting protein 1 |
NEDHCS, PML1, PMRED |
|
1008
|
|
|
Stannin |
- |
|
1009
|
|
|
Secondary ossification center associated regulator of chondrocyte maturation |
ASCL830, C2orf82, UNQ830 |
|
1010
|
|
|
Syntaphilin |
- |
|